SEC 13F Intelligence

Managers / Q4 2022 · view latest →

FARALLON CAPITAL MANAGEMENT, L.L.C.

CIK 0000909661 · ONE MARITIME PLAZA, SUITE 2100, SAN FRANCISCO, CA, 94111 · (415)421-2132

Reported Value
$15.3B
Q4 2022
Positions
232
Filings on Record
130
2019–present window
Filed
Feb 14, 2023
original filing

Summary

Farallon Capital Management, L.L.C. reported $15.3B in U.S.-listed holdings across 232 positions for Q4 2022.

Its largest position, IQV, represents 4.4% of the portfolio.

Compared with Q3 2022, the fund opened 14 new positions and exited 84.

Portfolio Metrics

Turnover
+14.1%
vs prior filed quarter
Top-10 Concentration
+31.0%
share of reported value
Largest Position
+4.4%
Iqvia
New / Exited
14 / 84
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $12.2BQ4 ’18Q1 ’19: $12.4BQ2 ’19: $12.1BQ3 ’19: $12.0BQ4 ’19: $12.5BQ4 ’19Q1 ’20: $16.2BQ2 ’20: $12.3BQ3 ’20: $14.3BQ4 ’20: $15.6BQ4 ’20Q1 ’21: $18.0BQ2 ’21: $24.3BQ3 ’21: $20.8BQ4 ’21: $19.3BQ4 ’21Q1 ’22: $22.7BQ2 ’22: $17.7BQ3 ’22: $18.2BQ4 ’22: $15.3BQ4 ’22Q1 ’23: $20.3BQ2 ’23: $17.9BQ3 ’23: $23.3BQ4 ’23: $22.9BQ4 ’23Q1 ’24: $22.1BQ2 ’24: $21.2BQ3 ’24: $20.6BQ4 ’24: $19.7BQ4 ’24Q1 ’25: $18.7BQ2 ’25: $23.7BQ3 ’25: $24.4BQ4 ’25: $21.2BQ4 ’25Q1 ’26: $18.4Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 70.0%ETP: 9.2%Other: 7.2%ADR: 7.1%GLOBAL: 4.4%Other: 2.1%
  • Common Stock · 70.0% · $11.1B
  • ETP · 9.2% · $1.5B
  • Other · 7.2% · $1.1B
  • ADR · 7.1% · $1.1B
  • GLOBAL · 4.4% · $696M
  • Other · 2.1% · $336M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
INTUINTUITNEW+902.1K902.1K+$351M$351M
MDGLMADRIGAL PHARMACEUTICALS INCNEW+153.0K153.0K+$44M$44M
PACBPACIFIC BIOSCIENCES CALIF INNEW+4.00M4.00M+$33M$33M
UNITY SOFTWARE INCNEW+30.50M30.50M+$23M$23M
BNTXBIONTECH SENEW+140.0K140.0K+$21M$21M
PROMETHEUS BIOSCIENCES INCNEW+145.1K145.1K+$16M$16M
RETAEURREATA PHARMACEUTICALS INCNEW+332.0K332.0K+$13M$13M
ZYMEZYMEWORKS DEL INCNEW+1.50M1.50M+$12M$12M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2022

47 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1IQVIQVIA HLDGS INChistory →COM4.38%$668M3.26M
2TMOTHERMO FISHER SCIENTIFIC INChistory →COM4.19%$640M1.16M
3TRUTRANSUNIONhistory →COM3.30%$503M8.86M
4CRMSALESFORCE INChistory →COM3.29%$501M3.78M
5ARMKARAMARKhistory →COM2.93%$448M10.83M
6BSXBOSTON SCIENTIFIC CORPhistory →COM2.81%$428M9.26M
7MSFTMICROSOFT CORPhistory →COM2.65%$405M1.69M
8AZNNASTRAZENECA PLChistory →SPONSORED ADR2.61%$398M5.88M
9CNCCENTENE CORP DELhistory →COM2.47%$377M4.59M
10SPGIS&P GLOBAL INChistory →COM2.36%$361M1.08M
11INTUINTUIThistory →COM2.30%$351M902.1K
12YMMFULL TRUCK ALLIANCE CO LTDhistory →SPONSORED ADS2.28%$348M43.44M
13EFXEQUIFAX INChistory →COM2.17%$331M1.70M
14SHWSHERWIN WILLIAMS COhistory →COM2.16%$329M1.39M
15ELVELEVANCE HEALTH INChistory →COM2.13%$325M634.3K
16HWMHOWMET AEROSPACE INChistory →COM2.09%$320M8.11M
17MAMASTERCARD INCORPORATEDhistory →CL A2.09%$319M916.2K
18IQIYI INCNOTE 2.000% 4/0 · NOTE 4.000%12/12.04%$311M424.67M
19DTDYNATRACE INChistory →COM NEW1.99%$303M7.92M
20ZEN1EURZENDESK INCREVEALEDhistory →COM1.94%$296M3.89M
21WABWABTEChistory →COM1.79%$273M2.74M
22GOOGALPHABET INChistory →CAP STK CL C1.76%$269M3.03M
23NOWSERVICENOW INChistory →COM1.70%$260M668.6K
24VVISA INChistory →COM CL A1.70%$259M1.25M
25BXBLACKSTONE INChistory →COM1.58%$241M3.25M
26AON PLCSHS CL A1.55%$237M788.1K
27BABAALIBABA GROUP HLDG LTDhistory →SPONSORED ADS1.54%$234M2.66M
28PINDUODUO INCNOTE 12/01.39%$213M227.51M
29XYZBLOCK INChistory →CL A1.33%$202M3.22M
30NYTNEW YORK TIMES COhistory →CL A1.29%$197M6.07M
31UTHUNITED THERAPEUTICS CORP DELhistory →COM1.20%$182M655.9K
32CSGPCOSTAR GROUP INChistory →COM1.16%$176M2.28M
33EX9EXELIXIS INChistory →COM1.14%$174M10.87M
34SWCHEURSWITCHREVEALEDhistory →CLA1.09%$167M4.96M
35BIIBBIOGEN INChistory →COM1.08%$164M592.7K
36ABBVABBVIE INChistory →COM0.99%$152M939.2K
37HUMHUMANA INChistory →COM0.91%$138M270.4K
38BEAMBEAM THERAPEUTICS INChistory →COM0.87%$133M3.40M
39CLARIVATE PLCORD SHS0.83%$127M15.18M
40SRPTSAREPTA THERAPEUTICS INChistory →COM0.79%$120M928.9K
41HELLO GROUP INCNOTE 1.250% 7/00.78%$118M123.45M
42MASI*MASIMO CORPhistory →COM0.74%$112M758.5K
43SEA LTDNOTE 0.250% 9/10.72%$111M150.00M
44PCGPG&E CORPhistory →COM0.55%$84M5.16M
45BEKEKE HLDGS INChistory →SPONSORED ADS0.53%$80M5.76M
46CYTKCYTOKINETICS INChistory →COM NEW0.51%$78M1.70M
47LUFAX HOLDING LTDADS REP SHS CL A0.49%$75M38.44M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026REVEALED$18.4B174May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$21.2B151Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$24.4B144Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025REVEALED$23.7B143Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025REVEALED$18.7B143May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$19.7B138Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024REVEALED$20.6B154Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024REVEALED$21.2B158Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$22.1B167May 24, 2024RESTATEMENTchanges · EDGAR ↗
Q4 2023REVEALED$22.9B159Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023REVEALED$23.3B177Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023REVEALED$17.9B166Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023REVEALED$20.3B205May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$15.3B232Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022REVEALED$18.2B311Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022REVEALED$17.7B309Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022REVEALED$22.7B326May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021REVEALED$19.3B294Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021REVEALED$20.8B298Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021REVEALED$24.3B294Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$18.0B229May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020REVEALED$15.6B133Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020REVEALED$14.3B121Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020REVEALED$12.3B120Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020REVEALED$16.2B106May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$12.5B113Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019REVEALED$12.0B93Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$12.1B98Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$12.4B92May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018REVEALED$12.2B95Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • Farallon Capital Europe LLP028-11719

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.